Moneycontrol
HomeNewsBusinessReal EstateCOVID-19 impact: Pandemic to accelerate realty sector consolidation; larger builders to benefit
Trending Topics

COVID-19 impact: Pandemic to accelerate realty sector consolidation; larger builders to benefit

Cancellations are expected to increase for recently launched projects with lower customer advance build-up.

July 16, 2020 / 21:47 IST
Story continues below Advertisement

COVID-19 has led to inflows from both new and already booked sales having been adversely impacted and increased the stress levels on developer cashflows. This is expected to further accelerate the ongoing consolidation of the sector with larger, more established players gaining increased market share, an ICRA analysis has said.

Sectoral demand has witnessed considerable moderation and committed sales receivables have slowed down due to deferment of milestone-based payment demands, given the lower pace of execution, and delay in payments by some buyers on account of economic uncertainties.

Story continues below Advertisement

On the supply side as well, new launches have slowed down, and execution of ongoing projects has gotten hampered due to reduced labour presence and raw material supply chain disruptions.

As per ICRA’s analysis, large realty players with established market positions, strong balance sheets and adequate liquidity have weathered the storm better than smaller players, who have been finding it difficult to cope with the prevailing market conditions. Consequently, the already ongoing consolidation of the sector is expected to accelerate further, with larger, more established players gaining increased market share.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show